A suspected sugammadex-induced anaphylactic shock - A case report -
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구본성 | - |
dc.contributor.author | 이소정 | - |
dc.contributor.author | 나현우 | - |
dc.contributor.author | 강우빈 | - |
dc.contributor.author | 김상현 | - |
dc.date.accessioned | 2021-08-11T10:43:40Z | - |
dc.date.available | 2021-08-11T10:43:40Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1975-5171 | - |
dc.identifier.issn | 2383-7977 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5080 | - |
dc.description.abstract | Background: The reversal of a neuromuscular blockade has typically been achieved with a cholinesterase inhibitor and the concomitant use of an anticholinergic agent, and this remains a popular method. Since the introduction of sugammadex in the market, its use has been increasing because of the rapid recovery from a neuromuscular blockade achieved by rocuronium. The occurrence of anaphylaxis or an anaphylactic reaction resulting from sugammadex is rare and has been reported sparsely. Thus, one may not recognize the possibility of sugammadex-induced hypersensitivity when sudden lifethreatening hypotension occurs, especially without skin manifestations during the emergence of anesthesia. This may delay treatment and increase morbidity. Case: We report a case of a sugammadex-related hypersensitivity reaction which manifested as pure cardiovascular collapse during the emergence of anesthesia. Conclusions: We emphasize that vigilance should be paid for at least five minutes following sugammadex administration in daily clinical practice. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한마취통증의학회 | - |
dc.title | A suspected sugammadex-induced anaphylactic shock - A case report - | - |
dc.title.alternative | A suspected sugammadex-induced anaphylactic shock - A case report - | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Anesthesia and Pain Medicine, v.14, no.3, pp 294 - 298 | - |
dc.citation.title | Anesthesia and Pain Medicine | - |
dc.citation.volume | 14 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 294 | - |
dc.citation.endPage | 298 | - |
dc.identifier.kciid | ART002490715 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Anaphylaxis | - |
dc.subject.keywordAuthor | Hypersensitivity | - |
dc.subject.keywordAuthor | Sugammadex. | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.